How long should patients remain in the supine treatment position after intratympanic dexamethasone injection?

Soon H. Park, Changhun Park, Jin Y. Seo, Jae H. Cho, In S. Moon

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objectives/Hypothesis: Intratympanic dexamethasone injection (ITDI) is a widely accepted treatment for patients with sudden hearing loss. We investigated the appropriate patient wait time in the supine treatment position after ITDI.

Study Design: Prospective study.

Methods: In an in vivo animal study, 24 mice were injected intratympanically with dexamethasone. Perilymphatic fluid was sampled at 5, 10, 15, 20, 25, and 30 minutes postinjection. The dexamethasone concentration was analyzed using highperformance liquid chromatography. In a separate prospective clinical study, 79 patients with refractory sudden hearing loss underwent intratympanic injection. After the injection, patients remained in the supine position with the head rotated 45° to the unaffected side. Patients were divided into two groups according to the wait time in this treatment position postinjection: 30 minutes (n=47) and 10 minutes (n=32). Final hearing assessments were conducted 2 months after salvage treatment.

Results: In the in vivo animal study, the perilymphatic concentration of dexamethasone showed no significant increase after 10 minutes. In the clinical setting, hearing improvement according to Siegel's criteria was similar in the 30-minute (14/47) and 10-minute (10/32) groups (P=0.999). No significant differences in relative hearing gain was observed between the two groups (13.80±19.9 dB and 12.57±14.9 dB, respectively; P=0.766).

Conclusion: We suggest that 10 minutes is a sufficient time to remain in the supine treatment position after ITDI in patients with sudden hearing loss.

Original languageEnglish
Pages (from-to)2807-2810
Number of pages4
JournalLaryngoscope
Volume124
Issue number12
DOIs
Publication statusPublished - 2014 Dec 1

Fingerprint

Supine Position
Dexamethasone
Sudden Hearing Loss
Hearing
Therapeutics
Prospective Studies
Salvage Therapy
Liquid Chromatography
Intratympanic Injection
Head
Injections

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology

Cite this

Park, Soon H. ; Park, Changhun ; Seo, Jin Y. ; Cho, Jae H. ; Moon, In S. / How long should patients remain in the supine treatment position after intratympanic dexamethasone injection?. In: Laryngoscope. 2014 ; Vol. 124, No. 12. pp. 2807-2810.
@article{d81e80ca9b254d3caec91b1948814f6c,
title = "How long should patients remain in the supine treatment position after intratympanic dexamethasone injection?",
abstract = "Objectives/Hypothesis: Intratympanic dexamethasone injection (ITDI) is a widely accepted treatment for patients with sudden hearing loss. We investigated the appropriate patient wait time in the supine treatment position after ITDI.Study Design: Prospective study.Methods: In an in vivo animal study, 24 mice were injected intratympanically with dexamethasone. Perilymphatic fluid was sampled at 5, 10, 15, 20, 25, and 30 minutes postinjection. The dexamethasone concentration was analyzed using highperformance liquid chromatography. In a separate prospective clinical study, 79 patients with refractory sudden hearing loss underwent intratympanic injection. After the injection, patients remained in the supine position with the head rotated 45° to the unaffected side. Patients were divided into two groups according to the wait time in this treatment position postinjection: 30 minutes (n=47) and 10 minutes (n=32). Final hearing assessments were conducted 2 months after salvage treatment.Results: In the in vivo animal study, the perilymphatic concentration of dexamethasone showed no significant increase after 10 minutes. In the clinical setting, hearing improvement according to Siegel's criteria was similar in the 30-minute (14/47) and 10-minute (10/32) groups (P=0.999). No significant differences in relative hearing gain was observed between the two groups (13.80±19.9 dB and 12.57±14.9 dB, respectively; P=0.766).Conclusion: We suggest that 10 minutes is a sufficient time to remain in the supine treatment position after ITDI in patients with sudden hearing loss.",
author = "Park, {Soon H.} and Changhun Park and Seo, {Jin Y.} and Cho, {Jae H.} and Moon, {In S.}",
year = "2014",
month = "12",
day = "1",
doi = "10.1002/lary.24872",
language = "English",
volume = "124",
pages = "2807--2810",
journal = "Laryngoscope",
issn = "0023-852X",
publisher = "John Wiley and Sons Inc.",
number = "12",

}

How long should patients remain in the supine treatment position after intratympanic dexamethasone injection? / Park, Soon H.; Park, Changhun; Seo, Jin Y.; Cho, Jae H.; Moon, In S.

In: Laryngoscope, Vol. 124, No. 12, 01.12.2014, p. 2807-2810.

Research output: Contribution to journalArticle

TY - JOUR

T1 - How long should patients remain in the supine treatment position after intratympanic dexamethasone injection?

AU - Park, Soon H.

AU - Park, Changhun

AU - Seo, Jin Y.

AU - Cho, Jae H.

AU - Moon, In S.

PY - 2014/12/1

Y1 - 2014/12/1

N2 - Objectives/Hypothesis: Intratympanic dexamethasone injection (ITDI) is a widely accepted treatment for patients with sudden hearing loss. We investigated the appropriate patient wait time in the supine treatment position after ITDI.Study Design: Prospective study.Methods: In an in vivo animal study, 24 mice were injected intratympanically with dexamethasone. Perilymphatic fluid was sampled at 5, 10, 15, 20, 25, and 30 minutes postinjection. The dexamethasone concentration was analyzed using highperformance liquid chromatography. In a separate prospective clinical study, 79 patients with refractory sudden hearing loss underwent intratympanic injection. After the injection, patients remained in the supine position with the head rotated 45° to the unaffected side. Patients were divided into two groups according to the wait time in this treatment position postinjection: 30 minutes (n=47) and 10 minutes (n=32). Final hearing assessments were conducted 2 months after salvage treatment.Results: In the in vivo animal study, the perilymphatic concentration of dexamethasone showed no significant increase after 10 minutes. In the clinical setting, hearing improvement according to Siegel's criteria was similar in the 30-minute (14/47) and 10-minute (10/32) groups (P=0.999). No significant differences in relative hearing gain was observed between the two groups (13.80±19.9 dB and 12.57±14.9 dB, respectively; P=0.766).Conclusion: We suggest that 10 minutes is a sufficient time to remain in the supine treatment position after ITDI in patients with sudden hearing loss.

AB - Objectives/Hypothesis: Intratympanic dexamethasone injection (ITDI) is a widely accepted treatment for patients with sudden hearing loss. We investigated the appropriate patient wait time in the supine treatment position after ITDI.Study Design: Prospective study.Methods: In an in vivo animal study, 24 mice were injected intratympanically with dexamethasone. Perilymphatic fluid was sampled at 5, 10, 15, 20, 25, and 30 minutes postinjection. The dexamethasone concentration was analyzed using highperformance liquid chromatography. In a separate prospective clinical study, 79 patients with refractory sudden hearing loss underwent intratympanic injection. After the injection, patients remained in the supine position with the head rotated 45° to the unaffected side. Patients were divided into two groups according to the wait time in this treatment position postinjection: 30 minutes (n=47) and 10 minutes (n=32). Final hearing assessments were conducted 2 months after salvage treatment.Results: In the in vivo animal study, the perilymphatic concentration of dexamethasone showed no significant increase after 10 minutes. In the clinical setting, hearing improvement according to Siegel's criteria was similar in the 30-minute (14/47) and 10-minute (10/32) groups (P=0.999). No significant differences in relative hearing gain was observed between the two groups (13.80±19.9 dB and 12.57±14.9 dB, respectively; P=0.766).Conclusion: We suggest that 10 minutes is a sufficient time to remain in the supine treatment position after ITDI in patients with sudden hearing loss.

UR - http://www.scopus.com/inward/record.url?scp=84912106613&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84912106613&partnerID=8YFLogxK

U2 - 10.1002/lary.24872

DO - 10.1002/lary.24872

M3 - Article

C2 - 25111944

AN - SCOPUS:84912106613

VL - 124

SP - 2807

EP - 2810

JO - Laryngoscope

JF - Laryngoscope

SN - 0023-852X

IS - 12

ER -